You are here

Article Text

Article menu
Download PDFPDF
Economics
Simvastatin was cost effective across a broad range of risk and age groups

https://doi.org/10.1136/ebm.12.2.58

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • ↵†

      Heart Protection Study Collaborative Group. Lancet 2002;360:7–22.
      OpenUrlCrossRefPubMedWeb of Science

    • For correspondence: Heart Protection Study, Clinical Trial Service Unit, Oxford, UK. hps{at}ctsu.ox.ac.uk

    • Sources of funding: UK Medical Research Council; British Heart Foundation; Merck & Co; Roche Vitamins Ltd.

    Linked Articles

    • Other articles noted
      Other articles noted
      BMJ Publishing Group Ltd
      BMJ Evidence-Based Medicine 2007; 12 63-64 Published Online First: 30 Mar 2007. doi: 10.1136/ebm.12.2.63
    • Glossary
      Glossary
      BMJ Publishing Group Ltd
      BMJ Evidence-Based Medicine 2007; 12 63-63 Published Online First: 30 Mar 2007. doi: 10.1136/ebm.12.2.63-a